Can a simple drug stop dangerous leaks after pancreatic surgery?
NCT ID NCT03000946
First seen Nov 01, 2025 · Last updated Jun 18, 2026 · Updated 35 times
Summary
This study tested whether somatostatin works better than octreotide at preventing pancreatic fistula, a common and serious leak after pancreatic surgery. Over 650 adults having their pancreas removed were randomly assigned to one of the two drugs. The goal was to see which drug reduces the risk of moderate-to-severe leaks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC SURGERY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin Hospital
Paris, Paris, 75014, France
-
La Pitié Salpêtrière Hospital
Paris, 75013, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.